To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene AGLTABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
249 supporting clones for gene AGL back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
NM_000644.2   .a 1 to 7109 1 to 7109 exact RefSeq,   7109/7109
(100 %)
0 diff
(100 %id)
U84008   .a 1 to 7106 1 to 7104 W1398G tiling clone,   7104/7105
(99 %)
9 diff
(99.9 %id)
NM_000643.2   .b 1 to 7169 1 to 7169 exact RefSeq,   7169/7169
(100 %)
0 diff
(100 %id)
U84009   .b 1 to 7166 1 to 7164 W1398G tiling clone,   7164/7165
(99 %)
10 diff
(99.9 %id)
NM_000028.2   .c 1 to 7449 1 to 7449 exact RefSeq,   7449/7449
(100 %)
0 diff
(100 %id)
U84010   .c 1 to 7446 1 to 7444 W1398G tiling clone,   7444/7445
(99 %)
10 diff
(99.9 %id)
AL596505 human spinal cord .c 133 to 387 40 to 294       255/294
(86 %)
6 diff
(98.0 %id)
AL597857   .c 156 to 756 1 to 600       600/600
(100 %)
7 diff
(98.9 %id)
AL597859   .c 156 to 758 1 to 602       602/602
(100 %)
4 diff
(99.4 %id)
AL597843   .c 158 to 676 1 to 519       519/519
(100 %)
1 diff
(99.9 %id)
BF790070 muscle (skeletal) .c 158 to 532 1 to 375   available from MGC,   375/375
(100 %)
3 diff
(99.2 %id)
BC057220 skeletal muscle .c 159 to 1106 5 to 952   available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 948/978
(96 %)
1 diff
(99.9 %id)
BC020705 skeletal muscle .c 159 to 1104 1 to 944   tiling clone, available from MGC, AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 944/954
(98 %)
6 diff
(99.4 %id)
BF790828 muscle (skeletal) .c 159 to 875 1 to 707   available from MGC,   707/885
(79 %)
16 diff
(98.2 %id)
NM_000642.2   .d 1 to 7371 1 to 7371 exact RefSeq,   7371/7371
(100 %)
0 diff
(100 %id)
U84007   .d 1 to 7368 1 to 7366 W1398G tiling clone,   7366/7367
(99 %)
10 diff
(99.9 %id)
DB238887 trachea .d 16 to 602 2 to 588   capped   587/587
(100 %)
1 diff
(99.9 %id)
AA313745 colon .d 102 to 557 1 to 456       456/459
(99 %)
1 diff
(99.8 %id)
DA858213 placenta .d 246 to 811 2 to 567   capped   566/566
(100 %)
2 diff
(99.7 %id)
CB956780 Pooled-Glandular .d 278 to 945 1 to 674       674/762
(88 %)
12 diff
(98.5 %id)
BC078663 Glandular pool- thyroid, parathyroid,adrenal cortex, pineal gland, submandibular gland. .d 281 to 5300 1 to 5020 exact tiling clone, available from MGC, AAA   5020/5020
(100 %)
0 diff
(100 %id)
DA666221   .d 282 to 846 2 to 567   capped   566/566
(100 %)
3 diff
(99.5 %id)
BF431263 Kidney .d 337 to 1004 667 to 1       667/667
(100 %)
35 diff
(94.8 %id)
AL597963   .d 356 to 531 1 to 176       176/176
(100 %)
0 diff
(100 %id)
AB208867 brain .d 397 to 5638 1 to 5242 exact     5242/5242
(100 %)
1 diff
(100.0 %id)
BF382029 brain, primitive neuroectoderm .d 441 to 1204 1 to 770       770/801
(96 %)
41 diff
(94.9 %id)
DA447409 tongue, tumor tissue .d 456 to 1023 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
AA587891 colon, colon tumor RER+ .d 481 to 1010 530 to 1       530/530
(100 %)
2 diff
(99.7 %id)
AW449668   .d 518 to 981 16 to 478     Submitted on the opposite strand 463/478
(96 %)
13 diff
(97.3 %id)
AL589294 human spinal cord .d 538 to 1025 28 to 516       489/516
(94 %)
7 diff
(98.7 %id)
BM841341 lymph node, stomach .d 576 to 840 1 to 265       265/265
(100 %)
1 diff
(99.7 %id)
BM763428 myeloma .d 576 to 1031 1 to 456   AAA Internal priming: the 3' end of the oligo dT primed clone lies in the CDS 456/472
(96 %)
2 diff
(99.6 %id)
CF147446 lymph .d 612 to 1139 1 to 528       528/528
(100 %)
0 diff
(100 %id)
TI_154185397   .d 612 to 1354 85 to 831       747/998
(74 %)
35 diff
(96.5 %id)
AA748293 germinal center B cell .d 676 to 1244 567 to 1       567/567
(100 %)
31 diff
(94.6 %id)
AW502226 lymph .d 1136 to 1660 1 to 525       525/525
(100 %)
10 diff
(98.1 %id)
CF142311 lymph .d 1136 to 1632 1 to 497       497/497
(100 %)
6 diff
(98.8 %id)
CF142853 lymph .d 1136 to 1513 1 to 378       378/378
(100 %)
13 diff
(96.6 %id)
TI_154157556   .d 1143 to 1753 84 to 694       611/615
(99 %)
7 diff
(98.9 %id)
TI_154173294   .d 1143 to 1791 90 to 739       650/1035
(62 %)
8 diff
(99.3 %id)
TI_154174003   .d 1143 to 1678 95 to 631       537/1203
(44 %)
25 diff
(98.0 %id)
BI549335 brain, hippocampus .d 1777 to 2280 1 to 518       518/518
(100 %)
29 diff
(94.5 %id)
TI_44167465   .d 1781 to 2280 82 to 595       514/595
(86 %)
31 diff
(94.8 %id)
AL596579 human spinal cord .d 1800 to 2154 1 to 355       355/355
(100 %)
0 diff
(100 %id)
CN277274 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 1882 to 2347 1 to 466       466/466
(100 %)
0 diff
(100 %id)
BI562134 testis .d 2072 to 2706 1 to 653       653/654
(99 %)
35 diff
(94.7 %id)
BI562356 testis .d 2072 to 2705 1 to 637       637/637
(100 %)
14 diff
(97.9 %id)
TI_44350111   .d 2075 to 2706 122 to 771       650/772
(84 %)
37 diff
(95.3 %id)
TI_44350255   .d 2075 to 2705 129 to 762       634/762
(83 %)
17 diff
(97.8 %id)
BM806841 lymph, lymphoma, cell line .d 2093 to 3119 1 to 1039       1039/1041
(99 %)
21 diff
(98.0 %id)
BU595048 mixed (pool of 40 RNAs) .d 2551 to 3336 3 to 788       786/788
(99 %)
5 diff
(99.4 %id)
DA223932 brain .d 2552 to 3100 2 to 550   capped   549/549
(100 %)
0 diff
(100 %id)
BX490818   .d 2659 to 3194 1 to 537       537/537
(100 %)
2 diff
(99.7 %id)
BE093554 breast .d 2751 to 3125 392 to 18     Submitted on the opposite strand 375/400
(93 %)
2 diff
(99.5 %id)
CD655764 Embryonic Stem cells .d 2768 to 3547 3 to 782       780/782
(99 %)
10 diff
(98.8 %id)
DA223698 brain .d 2895 to 3452 2 to 559   capped   558/558
(100 %)
0 diff
(100 %id)
AL708283 human skeletal muscle .d 2906 to 3142 1 to 243       243/246
(98 %)
11 diff
(95.6 %id)
AL713116 human skeletal muscle .d 2960 to 3515 1 to 556       556/556
(100 %)
2 diff
(99.7 %id)
DA816834   .d 3061 to 3631 2 to 572   capped   571/571
(100 %)
0 diff
(100 %id)
BF802569 colon_ins .d 3084 to 3539 469 to 14     Submitted on the opposite strand 456/469
(97 %)
0 diff
(100 %id)
AL699874 human skeletal muscle .d 3124 to 3817 1 to 694       694/694
(100 %)
1 diff
(99.9 %id)
F00985 leg muscle, skeletal muscle .d 3157 to 3485 1 to 337       337/338
(99 %)
11 diff
(96.8 %id)
F01099 leg muscle, skeletal muscle .d 3263 to 3596 1 to 337       337/337
(100 %)
6 diff
(98.3 %id)
AL700198 human skeletal muscle .d 3268 to 4073 1 to 807       807/808
(99 %)
4 diff
(99.6 %id)
CN277275 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .d 3274 to 3635 1 to 362       362/362
(100 %)
0 diff
(100 %id)
AL700494 human skeletal muscle .d 3344 to 3874 1 to 531       531/531
(100 %)
1 diff
(99.9 %id)
DA225189 brain .d 3432 to 3979 2 to 549   capped   548/548
(100 %)
0 diff
(100 %id)
AW504149 lymph .d 3551 to 3989 8 to 446       439/448
(97 %)
8 diff
(98.3 %id)
TI_154160266   .d 3551 to 4092 86 to 634       549/565
(97 %)
18 diff
(96.9 %id)
BF908582 uterus_tumor .d 3586 to 3994 418 to 10     Submitted on the opposite strand 410/418
(98 %)
2 diff
(99.6 %id)
BX499961 Liver .d 3606 to 4180 1 to 575       575/575
(100 %)
0 diff
(100 %id)
DA455232 tongue, tumor tissue .d 3670 to 4259 2 to 593   capped   592/592
(100 %)
2 diff
(99.7 %id)
BQ962659 leiomyosarcoma, uterus .d 3709 to 4529 1 to 827       827/913
(90 %)
9 diff
(99.1 %id)
DA215150 brain .d 3773 to 4306 2 to 535   capped   534/534
(100 %)
0 diff
(100 %id)
BF574461 muscle (skeletal) .d 3901 to 4572 1 to 667       667/763
(87 %)
16 diff
(98.0 %id)
BQ217878 embryonal carcinoma, cell line, testis .d 4103 to 4878 1 to 777       777/873
(89 %)
3 diff
(99.7 %id)
BF673645 Prostate .d 4137 to 4837 1 to 700       700/814
(85 %)
37 diff
(95.5 %id)
AL600525   .d 4143 to 4812 1 to 671       671/671
(100 %)
2 diff
(99.8 %id)
DA172945 amygdala .d 4144 to 4703 2 to 561   capped   560/560
(100 %)
0 diff
(100 %id)
AL599213   .d 4299 to 4839 1 to 543       543/547
(99 %)
7 diff
(98.8 %id)
DB148423 thymus .d 4348 to 4908 2 to 563   capped   562/562
(100 %)
3 diff
(99.5 %id)
AA789063 bone marrow stroma .d 4355 to 4881 1 to 531     Submitted on the opposite strand 531/641
(82 %)
34 diff
(94.7 %id)
AA449284   .d 4384 to 4733 1 to 351       351/351
(100 %)
2 diff
(99.5 %id)
CD687536 normal nasopharynx .d 4395 to 4994 35 to 634       600/634
(94 %)
7 diff
(98.9 %id)
DA989920 synovial membrane tissue from rheumatioidarthritis .d 4486 to 5012 2 to 528   capped   527/527
(100 %)
0 diff
(100 %id)
DA791652 brain .d 4524 to 5081 2 to 561   capped   560/560
(100 %)
2 diff
(99.7 %id)
DB204290 trachea .d 4576 to 5142 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
AI652502 pooled germ cell tumors .d 4595 to 5314 725 to 6       720/725
(99 %)
1 diff
(99.9 %id)
BX498417 Liver .d 4610 to 5290 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
BX482604   .d 4611 to 5217 1 to 606       606/606
(100 %)
4 diff
(99.4 %id)
BF670734 muscle (skeletal) .d 4667 to 5268 1 to 591       591/841
(70 %)
20 diff
(97.7 %id)
BG500015 adenocarcinoma, Prostate .d 4694 to 5303 1 to 613       613/756
(81 %)
9 diff
(98.9 %id)
AA018377 eye, retina .d 4711 to 5178 1 to 469       469/472
(99 %)
6 diff
(98.8 %id)
BX500784 Liver .d 4714 to 5216 1 to 503       503/503
(100 %)
0 diff
(100 %id)
CA315066 Human Lung Epithelial cells, lung .d 4722 to 5336 636 to 19   AAA   618/618
(100 %)
7 diff
(98.9 %id)
DA282200 corpus callosum .d 4732 to 5307 2 to 577   capped   576/576
(100 %)
1 diff
(99.9 %id)
BX482459   .d 4737 to 5148 9 to 420       412/420
(98 %)
0 diff
(100 %id)
BE466121 pooled germ cell tumors .d 4748 to 5310 575 to 11   AAA   565/645
(87 %)
4 diff
(99.4 %id)
BF435929 pooled .d 4748 to 5321 575 to 1       575/578
(99 %)
3 diff
(99.5 %id)
CA390727 eye, RPE/choroid .d 4790 to 5335 1 to 546       546/546
(100 %)
0 diff
(100 %id)
AA337399 endometrium .d 4796 to 5053 1 to 258       258/258
(100 %)
2 diff
(99.3 %id)
AA337598 endometrium .d 4796 to 5016 1 to 220       220/222
(99 %)
2 diff
(99.1 %id)
AW966522   .d 4797 to 5369 1 to 572       572/577
(99 %)
15 diff
(97.5 %id)
BG677533 skin, squamous cell carcinoma .d 4812 to 5699 1 to 888       888/889
(99 %)
10 diff
(98.9 %id)
BF695148 muscle (skeletal) .d 4817 to 5526 1 to 720       720/743
(96 %)
46 diff
(93.9 %id)
AI130981 heart .d 4883 to 5322 443 to 4       440/443
(99 %)
0 diff
(100 %id)
AI382887 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 4912 to 5318 407 to 1       407/407
(100 %)
7 diff
(98.3 %id)
AA449229   .d 4919 to 5322 409 to 2       408/409
(99 %)
0 diff
(100 %id)
BE223109 brain, oligodendroglioma .d 4972 to 5300 329 to 1       329/329
(100 %)
2 diff
(99.4 %id)
BI255036 cervical carcinoma cell line, cervix .d 4993 to 5760 1 to 757       757/761
(99 %)
16 diff
(97.9 %id)
DA162252 amygdala .d 4997 to 5574 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
BX500476 Liver .d 4999 to 5736 1 to 738       738/738
(100 %)
2 diff
(99.8 %id)
DA363823 subthalamic nucleus .d 5098 to 5662 2 to 566   capped   565/565
(100 %)
1 diff
(99.9 %id)
AU309505 neuroblastoma .d 5114 to 5669 1 to 556       556/556
(100 %)
1 diff
(99.9 %id)
BM785811 Ascites, stomach .d 5192 to 5832 1 to 641       641/641
(100 %)
2 diff
(99.7 %id)
T27720 testis .d 5271 to 5528 1 to 258       258/258
(100 %)
0 diff
(100 %id)
AW951844   .d 5278 to 5894 1 to 620       620/622
(99 %)
17 diff
(97.3 %id)
BX501049 Liver .d 5278 to 5942 1 to 667       667/667
(100 %)
3 diff
(99.6 %id)
DB282967 uterus .d 5284 to 5839 2 to 557   capped   556/556
(100 %)
0 diff
(100 %id)
CD643585 Embryonic Stem cells .d 5288 to 6083 9 to 796       788/830
(94 %)
18 diff
(97.9 %id)
AW182611 pooled .d 5289 to 6001 713 to 1   tiling clone,   713/713
(100 %)
1 diff
(99.9 %id)
AU139251 placenta .d 5308 to 6084 2 to 776   capped   775/822
(94 %)
14 diff
(98.3 %id)
DB170731 kidney, tumor tissue .d 5314 to 5885 2 to 574   capped   573/573
(100 %)
2 diff
(99.7 %id)
C05013 heart .d 5335 to 5751 1 to 417       417/417
(100 %)
4 diff
(99.1 %id)
C05605 heart .d 5335 to 5568 1 to 234       234/234
(100 %)
0 diff
(100 %id)
BX506126   .d 5371 to 5841 9 to 480       472/480
(98 %)
6 diff
(98.8 %id)
BF671682 muscle (skeletal) .d 5374 to 6042 1 to 656       656/830
(79 %)
27 diff
(96.8 %id)
FN135775 breast carcinoma .d 5410 to 5509 100 to 1     Submitted on the opposite strand 100/100
(100 %)
4 diff
(96.0 %id)
DA586535 lung .d 5433 to 5960 2 to 529   capped   528/528
(100 %)
0 diff
(100 %id)
DB001560 breast, tumor tissue .d 5456 to 5994 2 to 541   capped   540/540
(100 %)
2 diff
(99.7 %id)
BE541603 cervix .d 5507 to 6199 1 to 690       690/690
(100 %)
25 diff
(96.4 %id)
BF673012 muscle (skeletal) .d 5520 to 6189 1 to 662       662/880
(75 %)
18 diff
(98.0 %id)
AK130308 Prostate .d 5575 to 7368 1 to 1795   tiling clone, available from FLJ,   1795/1795
(100 %)
1 diff
(100.0 %id)
DA536646 heart .d 5593 to 5900 2 to 310   capped   309/309
(100 %)
1 diff
(99.7 %id)
AV682868 hepatocellular carcinoma .d 5614 to 6007 1 to 394       394/394
(100 %)
0 diff
(100 %id)
FN101623 breast carcinoma .d 5644 to 5770 129 to 1     Submitted on the opposite strand 129/129
(100 %)
3 diff
(97.7 %id)
AW630019 2 pooled high-grade transitional celltumors, genitourinary tract .d 5721 to 6297 10 to 586       577/586
(98 %)
6 diff
(99.0 %id)
AA247620   .d 5722 to 5947 1 to 225       225/225
(100 %)
4 diff
(98.3 %id)
BQ346377 nervous_tumor .d 5756 to 6127 381 to 11       371/381
(97 %)
0 diff
(100 %id)
BM149003 leukopheresis .d 5789 to 6198 1 to 410       410/410
(100 %)
5 diff
(98.8 %id)
AU116995 whole embryo, mainly head .d 5795 to 6585 2 to 788   capped   787/858
(91 %)
9 diff
(99.0 %id)
BE251031 eye, retinoblastoma .d 5797 to 6304 1 to 509       509/509
(100 %)
4 diff
(99.3 %id)
DR423032 eye, Pterygium .d 5802 to 6576 1 to 775       775/778
(99 %)
6 diff
(99.3 %id)
BG619497 placenta .d 5886 to 6562 1 to 676       676/681
(99 %)
21 diff
(97.0 %id)
CD512229 Pooled-Skin .d 5904 to 6409 1 to 510       510/644
(79 %)
9 diff
(98.7 %id)
BG025161 lymph, lymphoma, cell line .d 6233 to 6476 403 to 648       619/649
(95 %)
12 diff
(98.2 %id)
DB379500 placenta .d 6774 to 7361 588 to 1       588/589
(99 %)
22 diff
(96.3 %id)
AU143939 whole embryo, mainly head .d 6820 to 7368 546 to 1       546/546
(100 %)
13 diff
(97.7 %id)
AA017181 eye, retina .d 6954 to 7361 411 to 1       411/411
(100 %)
3 diff
(99.3 %id)
NM_000646.2   .e 1 to 7182 1 to 7182 exact RefSeq,   7182/7182
(100 %)
0 diff
(100 %id)
U84011   .e 1 to 7179 1 to 7177 I4L W1382G tiling clone,   7177/7178
(99 %)
11 diff
(99.9 %id)
M85168 muscle .f 1 to 7179 1 to 7179 W1381G tiling clone,   7179/7180
(99 %)
10 diff
(99.9 %id)
NM_000645.2   .f 1 to 7182 1 to 7182 exact RefSeq,   7182/7182
(100 %)
0 diff
(100 %id)
DR002471 fetal brain .g 1 to 632 1 to 631   tiling clone,   631/631
(100 %)
7 diff
(98.9 %id)
DA992590 synovial membrane tissue from rheumatioidarthritis .g 163 to 691 2 to 530 exact tiling clone, capped   529/529
(100 %)
0 diff
(100 %id)
BF104893 Kidney .h 1 to 636 1 to 631 L39S I40L N41T Y42I H43I ... tiling clone,   631/835
(75 %)
24 diff
(97.2 %id)
DA102139 cerebellum .i-u 1 to 590 2 to 591 exact tiling clone, to resequence, capped   590/590
(100 %)
1 diff
(99.9 %id)
FN106653 breast carcinoma .i-u 1230 to 1330 104 to 3   tiling clone, Submitted on the opposite strand 102/111
(91 %)
0 diff
(100 %id)
DA893920 skeletal muscle .i-u 1248 to 1782 2 to 536   tiling clone, capped   535/535
(100 %)
2 diff
(99.7 %id)
FN060675 breast carcinoma .i-u 1251 to 1340 92 to 1     Submitted on the opposite strand 92/92
(100 %)
1 diff
(99.0 %id)
R24014 placenta .i-u 1311 to 1701 1 to 404       404/404
(100 %)
20 diff
(95.1 %id)
BF790749 muscle (skeletal) .i-u 1396 to 2056 1 to 657       657/828
(79 %)
19 diff
(97.8 %id)
EL953827 eyeball .i-u 1417 to 1765 28 to 374   tiling clone,   347/374
(92 %)
9 diff
(97.6 %id)
AA090213   .i-u 1445 to 1737 1 to 293       293/293
(100 %)
1 diff
(99.7 %id)
BF671643 muscle (skeletal) .i-u 1451 to 2075 1 to 626       626/890
(70 %)
15 diff
(98.4 %id)
BG565601 Liver .i-u 1458 to 2270 1 to 813       813/813
(100 %)
14 diff
(98.3 %id)
BF964273 nervous_normal .i-u 1483 to 1932 1 to 457       457/474
(96 %)
34 diff
(92.9 %id)
FN145879 breast carcinoma .i-u 1556 to 1678 120 to 1     Submitted on the opposite strand 120/120
(100 %)
4 diff
(96.7 %id)
BG565125 Liver .i-u 1580 to 2277 1 to 699       699/699
(100 %)
3 diff
(99.6 %id)
FN141571 breast carcinoma .i-u 1582 to 1672 1 to 90       90/93
(96 %)
3 diff
(96.8 %id)
BF576593 muscle (skeletal) .i-u 1596 to 2273 1 to 674       674/676
(99 %)
8 diff
(98.9 %id)
AA233696 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 1627 to 2118 1 to 488   tiling clone,   488/488
(100 %)
8 diff
(98.4 %id)
BG283472 adenocarcinoma, cell line, Prostate .i-u 1644 to 2383 1 to 738       738/738
(100 %)
8 diff
(99.0 %id)
TI_149315127   .i-u 1690 to 2501 907 to 98   AAA   810/977
(82 %)
10 diff
(99.0 %id)
BM685727 eye, Retina Foveal and Macular .i-u 1691 to 2298 8 to 616       609/616
(98 %)
6 diff
(99.1 %id)
AI097561 brain, glioblastoma (pooled) .i-u 1728 to 2501 788 to 12   AAA   777/782
(99 %)
11 diff
(98.6 %id)
BF576222 muscle (skeletal) .i-u 1730 to 2350 1 to 608       608/783
(77 %)
18 diff
(97.8 %id)
BF577313 muscle (skeletal) .i-u 1730 to 2388 1 to 656       656/844
(77 %)
15 diff
(98.3 %id)
AI927887 Kidney .i-u 1738 to 2501 769 to 5       765/769
(99 %)
0 diff
(100 %id)
FN074808 breast carcinoma .i-u 1746 to 1826 1 to 81       81/82
(98 %)
1 diff
(98.8 %id)
BM999394 Fibrosarcoma .i-u 1748 to 2494 765 to 19   AAA   747/747
(100 %)
2 diff
(99.8 %id)
BX502207 Liver .i-u 1753 to 2459 1 to 704       704/704
(100 %)
9 diff
(98.8 %id)
AV706304 adrenal gland .i-u 1768 to 2476 61 to 769       709/769
(92 %)
6 diff
(99.3 %id)
BQ045144 lung, Primary Lung Cystic Fibrosis EpithelialCells .i-u 1774 to 2501 746 to 19   AAA   728/728
(100 %)
2 diff
(99.8 %id)
FN120694 breast carcinoma .i-u 1801 to 1917 1 to 117       117/117
(100 %)
2 diff
(98.3 %id)
BQ025555 placenta .i-u 1818 to 2501 701 to 19   AAA   683/697
(97 %)
6 diff
(99.2 %id)
FN120730 breast carcinoma .i-u 1820 to 1899 1 to 80       80/80
(100 %)
2 diff
(97.5 %id)
AW190082 serous papillary carcinoma, high grade, 2pooled tumors, uterus .i-u 1824 to 2501 698 to 17   AAA   682/703
(97 %)
28 diff
(96.1 %id)
R34222 placenta .i-u 1826 to 2132 1 to 308   fully sequenced,   308/308
(100 %)
9 diff
(97.1 %id)
AI219999 pooled .i-u 1842 to 2501 659 to 2       658/659
(99 %)
0 diff
(100 %id)
AI932334 pooled .i-u 1845 to 2499 653 to 1       653/653
(100 %)
33 diff
(95.0 %id)
CB162142 Liver .i-u 1846 to 2492 647 to 1     Submitted on the opposite strand 647/647
(100 %)
0 diff
(100 %id)
BF887303 testis_normal .i-u 1849 to 2055 232 to 22     Submitted on the opposite strand 211/232
(90 %)
0 diff
(100 %id)
BF887304 testis_normal .i-u 1849 to 2040 193 to 3     Submitted on the opposite strand 191/193
(98 %)
0 diff
(100 %id)
TI_159723641   .i-u 1861 to 2501 732 to 92   AAA   641/1006
(63 %)
0 diff
(100 %id)
CA945170 Human Lung Epithelial cells, lung .i-u 1861 to 2501 659 to 19   AAA   641/657
(97 %)
0 diff
(100 %id)
BQ024943 placenta .i-u 1871 to 2494 641 to 19   AAA   623/623
(100 %)
2 diff
(99.7 %id)
AW272686 colon, moderately-differentiated adenocarcinoma .i-u 1876 to 2501 627 to 1       627/631
(99 %)
1 diff
(99.9 %id)
AW172866 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i-u 1885 to 2494 620 to 11   AAA   610/613
(99 %)
6 diff
(99.1 %id)
BQ025177 placenta .i-u 1895 to 2501 624 to 19   AAA   606/606
(100 %)
1 diff
(99.9 %id)
AW084630 connective tissue, five pooled sarcomas, including myxoidliposarcoma, solitary fibrous tumor, malignant fibroushistiocytoma, gastrointestinal stromal tumor, andmesothelioma .i-u 1913 to 2497 586 to 1       586/590
(99 %)
6 diff
(99.0 %id)
AI671033 moderately-differentiated endometrialadenocarcinoma, 3 pooled tumors, uterus .i-u 1919 to 2501 618 to 38   AAA   581/581
(100 %)
29 diff
(95.1 %id)
BE973804 Prostate .i-u 1921 to 2472 1 to 555       555/824
(67 %)
16 diff
(98.1 %id)
BE044053 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 1924 to 2501 590 to 13   AAA   578/578
(100 %)
3 diff
(99.5 %id)
BF002959 Prostate .i-u 1925 to 2497 574 to 2       573/574
(99 %)
0 diff
(100 %id)
AI253231 Kidney .i-u 1927 to 2494 582 to 22   AAA   561/568
(98 %)
13 diff
(97.8 %id)
CB162266 Liver .i-u 1939 to 2492 555 to 1     Submitted on the opposite strand 555/555
(100 %)
4 diff
(99.3 %id)
DB299214 cerebellum .i-u 1943 to 2494 552 to 1   to resequence,   552/552
(100 %)
0 diff
(100 %id)
BF574614 muscle (skeletal) .i-u 1945 to 2501 1 to 555       555/627
(88 %)
4 diff
(99.4 %id)
CB162037 Liver .i-u 1971 to 2492 522 to 1     Submitted on the opposite strand 522/522
(100 %)
0 diff
(100 %id)
AI290110 serous papillary carcinoma, high grade, 2pooled tumors, uterus .i-u 1972 to 2505 536 to 2   tiling clone,   535/536
(99 %)
0 diff
(100 %id)
AA809461 germinal center B cell .i-u 1973 to 2501 545 to 20   AAA   526/526
(100 %)
8 diff
(98.5 %id)
AI687125 poorly-differentiated endometrialadenocarcinoma, 2 pooled tumors, uterus .i-u 1979 to 2494 541 to 28   AAA   514/514
(100 %)
11 diff
(97.9 %id)
BQ021859 placenta .i-u 1994 to 2501 525 to 18   AAA   508/508
(100 %)
1 diff
(99.9 %id)
BF195777 Kidney .i-u 1996 to 2501 514 to 10       505/514
(98 %)
0 diff
(100 %id)
AA729668 pooled germ cell tumors .i-u 1999 to 2501 505 to 1       505/505
(100 %)
16 diff
(96.9 %id)
FN062177 breast carcinoma .i-u 2005 to 2091 1 to 86       86/102
(84 %)
2 diff
(98.1 %id)
CA450457 Human Lung Epithelial cells, lung .i-u 2018 to 2501 500 to 19   AAA   482/482
(100 %)
3 diff
(99.4 %id)
AI093425 uterus .i-u 2032 to 2494 476 to 15   AAA   462/462
(100 %)
7 diff
(98.5 %id)
AI376681   .i-u 2036 to 2501 470 to 5       466/470
(99 %)
0 diff
(100 %id)
AA233141.
matches multiple genes
mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .i-u 2041 to 2501 468 to 1     also hits gene L3MBTL2 468/470
(99 %)
45 diff
(90.5 %id)
AI424189 brain, glioblastoma (pooled) .i-u 2046 to 2501 453 to 1       453/453
(100 %)
7 diff
(98.5 %id)
AA668425   .i-u 2051 to 2501 450 to 1       450/450
(100 %)
2 diff
(99.6 %id)
AA668418   .i-u 2055 to 2495 439 to 1       439/439
(100 %)
14 diff
(96.9 %id)
AA664867 alveolar rhabdomyosarcoma .i-u 2060 to 2470 411 to 1       411/411
(100 %)
2 diff
(99.6 %id)
FN144137 breast carcinoma .i-u 2079 to 2170 1 to 90       90/90
(100 %)
5 diff
(94.5 %id)
AW118550 brain, tumor, 5 pooled (see description) .i-u 2091 to 2497 415 to 6       410/415
(98 %)
0 diff
(100 %id)
AI376682   .i-u 2094 to 2498 408 to 1       408/459
(88 %)
49 diff
(89.4 %id)
AI435501 pooled .i-u 2095 to 2501 415 to 9       407/415
(98 %)
0 diff
(100 %id)
BF886121 testis_normal .i-u 2099 to 2473 5 to 376       372/379
(98 %)
6 diff
(98.5 %id)
AI439128 Kidney .i-u 2102 to 2494 405 to 13   AAA   393/393
(100 %)
0 diff
(100 %id)
R34338 placenta .i-u 2128 to 2481 367 to 1   fully sequenced,   367/367
(100 %)
24 diff
(93.5 %id)
BU752994 placenta .i-u 2156 to 2494 356 to 18   AAA   339/339
(100 %)
1 diff
(99.8 %id)
FN055851 breast carcinoma .i-u 2170 to 2274 110 to 6     Submitted on the opposite strand 105/110
(95 %)
0 diff
(100 %id)
AI419635 brain, glioblastoma (pooled) .i-u 2187 to 2501 318 to 1       318/436
(72 %)
4 diff
(99.1 %id)
AW276607 lung, two pooled squamous cell carcinomas .i-u 2195 to 2486 292 to 1       292/358
(81 %)
15 diff
(95.9 %id)
BQ022584 placenta .i-u 2241 to 2494 271 to 18   AAA   254/254
(100 %)
0 diff
(100 %id)
AW130147 uterus, well-differentiated endometrialadenocarcinoma, 7 pooled tumors .i-u 2256 to 2501 247 to 2       246/247
(99 %)
0 diff
(100 %id)
FN087291 breast carcinoma .i-u 2349 to 2432 1 to 80       80/84
(95 %)
8 diff
(90.5 %id)
FN051080 breast carcinoma .i-u 2375 to 2444 70 to 1     Submitted on the opposite strand 70/71
(98 %)
0 diff
(100 %id)
FN077180 breast carcinoma .i-u 2389 to 2454 65 to 1     Submitted on the opposite strand 65/65
(100 %)
1 diff
(98.5 %id)
GD153404   .i-u 2393 to 2501 1 to 109       109/121
(90 %)
1 diff
(99.2 %id)
FN116423 breast carcinoma .i-u 2395 to 2451 58 to 1     Submitted on the opposite strand 58/59
(98 %)
1 diff
(98.4 %id)
AI355368 lung .i-u 2396 to 2494 112 to 14   AAA   99/99
(100 %)
0 diff
(100 %id)
C00487   .i-u 2406 to 2504 1 to 99       99/99
(100 %)
0 diff
(100 %id)
FN125458 breast carcinoma .i-u 2422 to 2496 75 to 4     Submitted on the opposite strand 72/75
(96 %)
0 diff
(100 %id)
DA232743 brain .j-u 1 to 566 2 to 567 exact tiling clone, capped   566/566
(100 %)
0 diff
(100 %id)
AL700354 human skeletal muscle .j-u 222 to 770 1 to 549 exact tiling clone,   549/549
(100 %)
2 diff
(99.7 %id)
DA239512 brain .j-u 615 to 1201 2 to 588   tiling clone, capped   587/587
(100 %)
0 diff
(100 %id)
BX092786   Gene AGL, variant not shown         Suspected internal deletion, this clone was ignored    
DT220391 brain Gene AGL, variant not shown         Suspected internal deletion, this clone was ignored    
AV681879 hepatocellular carcinoma Gene AGL, variant not shown         Suspected internal deletion, this clone was ignored    
R02741 liver and spleen Gene AGL, variant not shown              
R02742 liver and spleen Gene AGL, variant not shown              
H57812 liver and spleen Gene AGL, variant not shown              
H59933 liver and spleen Gene AGL, variant not shown              
AA443773   Gene AGL, variant not shown         Suspected internal deletion, this clone was ignored    
AA476828   Gene AGL, variant not shown         Suspected internal deletion, this clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h, .i-u, .j-u Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DCI